PRDX6 and ovarian carcinoma: In addition, withangulatin A, a covalent PRDX6 inhibitor which inhibited the peroxidase and PLA2 activities of PRDX6 (Figure S3C,D, Supporting Information),[15] profoundly suppressed the growth, migration, and invasion of ovarian cancer cells (Figure S3E,F, Supporting Information).